Navigation Links
Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device
Date:5/22/2012

WESTPORT, Conn., May 22, 2012 /PRNewswire/ -- Valeritas, the maker of V-Go™ Disposable Insulin Delivery Device, a new, simple disposable device for the delivery of insulin designed especially for adults with type 2 diabetes, has selected dLife to support its state-of-the-art patient engagement program. dLife, the number-one resource and community network for people living with diabetes, and Valeritas have co-developed V-Go Life, a comprehensive diabetes lifestyle management and support program designed to increase engagement of V-Go users. This collaboration is the first of its kind from dLife's recently launched Healthcare Solutions Group, an extension of the dLife media brand that works specifically with health plans, providers, and pharmaceutical and device manufacturers to provide them diabetes engagement, behavior change, and self-management programs.

"The V-Go Life program provides comprehensive support that also addresses the issue of compliance among people living with diabetes," said Kristine Peterson, CEO of Valeritas. "By extending our solution beyond the V-Go device, we can offer people with type 2 diabetes assistance and resources throughout their entire insulin treatment regimen. Our collaboration with dLife is part of Valeritas' strong commitment to improving the lives of people with diabetes."

In this partnership, dLife's Engagement Platform is leveraged to provide users customized content and tools. Resources provided on the website include articles, videos, recipes, polls, quizzes, diet and exercise tips, expert advice, questions of the week, and more that align with and support their personal diabetes management programs, and help support the use and adoption of V-Go. V-Go Life users will be engaged in a 360-degree disease management program that contains a curriculum aimed at helping them adopt and keep engaged with the V-Go product. This will allow them to stay informed and actively engaged in their progress with their personal diabetes self-management.

"We are excited to be working with Valeritas and with the V-Go, a simple product that helps with blood sugar control for adult patients with type 2 diabetes," said Adam Kaufman, PhD, General Manager of dLife Healthcare Solutions. "The V-Go is a device that clearly fits into peoples' diabetes lifestyles and aims to significantly improve self-care; and the V-Go Life solution, built on dLife content and technology, furthers Valeritas' commitment to support the entire diabetes self-management experience."  

The V-Go device makes insulin delivery convenient by delivering a continuous preset basal rate of insulin, as well as on-demand bolus dosing at mealtimes, for one 24-hour period. By eliminating the complicated regimen of injecting throughout the day and minimizing interruptions with daily activities, this method facilitates patient compliance with their therapy and may ultimately lead to improved glucose control. 

Kaufman continued, "The V-Go Life program is customized to the unique demographics and experiences of V-Go patients by drawing upon the diabetes expertise and support that people with diabetes need — something dLife has been offering to diabetes consumers for many years."

V-Go Life will be available at no cost only to patients currently using the V-Go device.  Patients on the V-Go device wishing to enroll in the V-Go Life program should call the 24/7 toll-free Valeritas customer care line at 1-866-881-1209.

For more information about dLife Healthcare Solutions' programs, contact Adam Kaufman at kaufman@dlife.com or 203-221-3442.

About Valeritas, Inc.

Valeritas is a medical technology company committed to the development and commercialization of innovative drug delivery solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of diabetes. The Valeritas medical technologies portfolio is headlined by the h-Patch™ technology. The V-Go Disposable Insulin Delivery Device, designed for the simple delivery of basal-bolus insulin therapy via a preset basal rate and on-demand bolus dosing at mealtimes, is the first use of the h-Patch™ technology.

Headquartered in Bridgewater, NJ, Valeritas operates its R&D and manufacturing in a state-of-the-art facility in Shrewsbury, MA. For more information on Valeritas and the V-Go™ Disposable Insulin Delivery Device, please visit www.valeritas.com and www.go-vgo.com.

About dLife – It's YOUR Diabetes Life!

dLife is the number-one community network and resource for millions of people with diabetes, their caregivers and healthcare providers. dLife engages this growing population in positive and proactive self-care across a variety of media channels. Its award-winning outlets include dLife.com, the leading online diabetes destination, attracting more than one million unique visitors a month, and featuring the widest and deepest variety of original content and resources anywhere; dLifeTV, the only national TV series dedicated to people with diabetes, with over half a million viewers, airing every Sunday on CNBC (7 p.m. ET); popular mobile applications; as well as consumer and professional programs driving proactive diabetes self-management.  dLife has been recognized with numerous media and editorial awards.

dLife Healthcare Solutions applies evidence-based content and technology solutions built specifically for health plans and healthcare providers who want to engage their diabetes populations as consumers of their own  healthcare and owners of their own condition. dLife has demonstrated positive and direct impact on health outcomes via a recently completed randomized trial performed by the Geisinger Healthcare System.

Join dLife on Facebook or follow dLife on Twitter. Watch us on YouTube.

dLife Media Contact:
Emma Ludwin
KNB Communications
203.504.8230 ext. 107
eludwin@knbpr.com

Valeritas Media Contact:
Shannon Coughlin
Twist
212.301.7209
scoughlin@twistmktg.com


'/>"/>
SOURCE dLife Healthcare Solutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeritas Announces $150 Million Financing
2. Valeritas Receives FDA 510(k) Clearance for the V-Go™ Disposable Insulin Delivery Device for Use with NovoLog®
3. Valeritas Receives FDA 510(k) Clearance for the V-Go™ Disposable Insulin Delivery Device
4. PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor
5. Angeion Selects Hendrik Struik for Board of Directors
6. Blue Mountain Hospital Selects Enterprise System from Prognosis HIS
7. FDA Selects CreatiVasc For New Innovation Pathway Program
8. Weill Cornell Medical College Selects Ingenuity® Variant Analysis™ and Ingenuity® iReport™ for Sequencing Core Facility
9. ASLAN Pharmaceuticals Selects PharmaNet/i3 as Strategic Partner For Oncology Development
10. Rubicon Genomics Selects Velesco to Manufacture its TransPLEX® RNA Amplification Kits for Clinical Diagnostic Use
11. Stryker Communications Selects Glowpoint to Enhance IP Video Platform for Operating Rooms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , Dec. 6, 2016   AlloSource ... cartilage, cellular, bone, skin and soft-tissue allografts for ... , Business Process Manager, for being named to ... Baldrige National Quality Award by the Commerce Department,s ... the organization,s commitment to process excellence. The Baldrige ...
(Date:12/6/2016)... 2016  BTL Aesthetics today announced the release ... Vanquish ME device was effectively redesigned for more ... targeted tissue. The result: Significantly better outcomes in ... Vanquish ME versus BTL Vanquish. "We ... their patients with the most highly-advanced devices on ...
(Date:12/6/2016)... Dec. 6, 2016 With opioids commonly used for pain ... prescription drug market that has led to nationwide fatalities. ... eight times stronger than heroin or morphine, resulting in likelihood of ... , ... vice president, clinical operations, Behavioral Health for HMC HealthWorks, explained the ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... 2016 (PRWEB) (PRWEB) December 07, 2016 , ... Man’s best ... Dermatitis Associated with Borrelia Infection” reveals that a condition similar to ... prestigious Journal of Veterinary Science & Medical Diagnosis. , Morgellons disease is an ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and ... The Holiday Party Season. Save Up To 33% Off Botox® and Juvederm® Products Now ... the Phoenix Valley with Delightful Deals on Botox® and Juvederm® just in ...
(Date:12/7/2016)... California (PRWEB) , ... December 07, 2016 , ... "ProBrand ... any and all media," said Christina Austin - CEO of Pixel Film Studios. , ... with easy to use drop zones. Editors can select from a variety of flip ...
(Date:12/7/2016)... ... 07, 2016 , ... “The Road To Restoration”: an informative and enlightening ... hour a week showing of hands. “The Road To Restoration” is the creation of ... familiar with the brass ring that you could reach out for, and grab, on ...
(Date:12/7/2016)... ... (PRWEB) December 07, 2016 , ... Angioma ... by cerebral cavernous angiomas, was awarded a grant from the Julian Grace Foundation ... New Mexico has more people with cavernous angioma than anywhere in the world. ...
Breaking Medicine News(10 mins):